Moderate to Severe Refractory Autoimmune Disease Clinical Trials in Shanghai, Shanghai Municipality

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases